Andreas Zeller
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, Effects and risks of endocrine disrupting chemicals, DNA Repair Mechanisms, Animal testing and alternatives, Genetically Modified Organisms Research
Most-Cited Works
- → Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2 ) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)(2018)505 cited
- → Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay(2017)73 cited
- → Permitted daily exposure limits for noteworthy N‐nitrosamines(2021)68 cited
- → Mutation as a Toxicological Endpoint for Regulatory Decision‐Making(2019)67 cited
- → Comet assay in reconstructed 3D human epidermal skin models--investigation of intra- and inter-laboratory reproducibility with coded chemicals(2013)63 cited
- → An appraisal of critical effect sizes for the benchmark dose approach to assess dose–response relationships in genetic toxicology(2017)54 cited
- → Improvement of antibiotic prescription in outpatient care: a cluster-randomized intervention study using a sentinel surveillance network of physicians(2014)53 cited
- → A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens(2018)33 cited
- → Correction to: An appraisal of critical effect sizes for the benchmark dose approach to assess dose–response relationships in genetic toxicology(2017)31 cited
- → Dose–response relationship of temozolomide, determined by the Pig-a, comet, and micronucleus assay(2017)23 cited